Schizophrenia trials in Chile

1 trial · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

• Phase 2Taking people
  A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis

  Where

  Antofagasta, Santiago

  Age

  55 years to 90 years

  People

  300 worldwide

  Run by

  MapLight Therapeutics

  See details and how to joinNCT06887192 · EU 2024-519820-26-00